Archive for the ‘biotech/medical’ category: Page 2102
Dec 26, 2018
Israeli company claims it has created new technology that can destroy cancerous tumors
Posted by Victoria Generao in category: biotech/medical
An Israeli company says it has developed a targeted radiation treatment that it claims can cure cancerous tumors.
“This is the first time in the world that you can treat solid tumors with alpha radiation,” Alpha Tau Medical’s CEO Uzi Sofer told the Times of Israel.
Dec 25, 2018
‘Hunger Hormone’ Ghrelin Aids Overindulgence
Posted by Genevieve Klien in categories: biotech/medical, food
Ghrelin, the hormone that makes you hungry, also makes food, and food smells, irresistibly appealing. Karen Hopkin reports.
‘Tis the season…for overeating! But it’s not just your lack of willpower or the omnipresent holiday treats. No, you can lay some of the blame on ghrelin. Because a new study shows that ghrelin, the hormone that makes you hungry, also makes food…and food smells…irresistibly appealing. The finding appears in the journal Cell Reports. [Jung Eun Han et al, Ghrelin Enhances Food Odor Conditioning in Healthy Humans: An fMRI Study].
Continue reading “‘Hunger Hormone’ Ghrelin Aids Overindulgence” »
Dec 25, 2018
2019 Preview: People will receive transfusions of artificial blood
Posted by Ian Hale in category: biotech/medical
Volunteers will be injected with red blood cells grown from stem cells in the lab. If it works it could mean blood donors are no longer required.
Dec 24, 2018
Are Stem Cell Injections Really a Miracle Cure for Everything From Cancer to Cellulite?
Posted by Genevieve Klien in category: biotech/medical
Dec 24, 2018
The Genetic Revolution
Posted by Genevieve Klien in categories: bioengineering, biotech/medical, genetics
CRISPR looks set to be the future of gene editing. But experts are cautioning that this revolutionary technique needs to be developed carefully. So what do the next few years hold?
Dec 24, 2018
There will be no old people – anti-aging SophieCo
Posted by Montie Adkins in categories: biotech/medical, life extension
Merry Christmas
Is the Fountain of Youth still just a dream, or does hope spring eternal when it comes to beating the curse of aging? Having haunted us for centuries, is a solution finally within our grasp? We spoke to Dr Aubrey de Grey, anti-aging pioneer, chief science officer, and co-founder of SENS Research Foundation.
Follow @SophieCo_RT
Continue reading “There will be no old people – anti-aging SophieCo” »
Dec 24, 2018
5 things to know about DNA tests before you send your spit
Posted by Genevieve Klien in categories: biotech/medical, information science
Companies use different algorithms based on different sets of data. Most of that data comes from people of recent European ancestry.
The problem, obviously, is that a lot of people don’t have grandparents or great-great-great-grandparents from England or Italy or Denmark. Most people on Earth, actually! That means if you’re from, say, Asia or Africa, you might not get as detailed a profile as you’d like.
My mother, who was born in the Philippines, actually got an update from 23andMe with new information about her heritage. Her history didn’t change. But as the company gets more DNA kits from people of Asian descent, the algorithm churns out modified results. Which is great … but that does mean right now, if you’re not white, you might have to wait a bit longer for more accurate results.
Dec 24, 2018
Bioquark Inc — Ectocrine Technologies — Mosquitos — Ira Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, business, chemistry, disruptive technology, genetics, health, life extension
New program coming on-line at Bioquark Inc. (www.bioquark.com) — Ectocrine interactions (the“Ectocrinome”) represents a completely unexplored area related to human health
https://www.prweb.com/releases/bioquark_inc_and_ectocrine_te…004155.htm
Tags: aging, bioquark, ectocrine, ectocrinome, health, ira pastor, mosquitos, natural products, wellness
Dec 24, 2018
Pediatric leukemia ‘super drug’ could be less than a decade away
Posted by Nicholi Avery in category: biotech/medical
Building on several years of research into a protein responsible for leukemia, a newly published paper has revealed success in slowing the progression of the deadly cancer in mouse models. The researchers suggest two new prospective therapies can now be combined into one “super drug” and progress into human clinical trials.